microRNA-132 regulates gene expression programs involved in microglial homeostasis

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• microRNA-132 (miR-132) is significantly downregulated in Alzheimer's disease (AD) brains.
• Increasing miR-132 in AD mouse models improves pathologies and cognitive function.
• Further investigation is needed to understand miR-132's pleiotropic effects for therapeutic development.

Purpose of the Study:

• To identify molecular pathways targeted by miR-132 in the mouse hippocampus.
• To analyze the effects of miR-132 modulation on microglial cell states.

Main Methods:

• Utilized miR-132 loss- and gain-of-function approaches.
• Employed single-cell transcriptomics, proteomics, and in silico AGO-CLIP datasets.
• Confirmed findings using human induced pluripotent stem cell-derived microglia.

Main Results:

• miR-132 modulation significantly impacts the transition of microglia from a disease-associated to a homeostatic state.
• Identified specific molecular pathways regulated by miR-132 in the hippocampus.
• Demonstrated miR-132's regulatory role in microglial state shifts in human cell cultures.

Conclusions:

• miR-132 plays a crucial role in regulating microglial states, shifting them towards homeostasis.
• These findings highlight miR-132 as a potential therapeutic target for Alzheimer's disease.
• Understanding miR-132's molecular targets is key for developing effective AD treatments.